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compiled an extensive and interesting review of recent literature that examines the relationship between known molecular paradigms of skin disease and intrinsic mitochondrial health. Whilst it is unrealistic for the authors to fully explore all recent advances within normal journal constraints, there are some surprising omissions, including our own detailed review of mtDNA and skin disease in 2000. Feichtinger et al (2) highlight the breadth of potential mitochondrial involvement in conditions not traditionally associated with metabolic or oxidative phosphorylation defects. On consideration however, it seems intuitive that any global defect of cell function is capable of exerting detrimental secondary effects on mitochondrial function. An example of this is mutation of the keratin 5 and 14 genes which are associated with the dermatological manifestation (e.g. skin blistering) of epidermolysis bullosa simplex. The altered mitochondrial network formation highlighted by Feichtinger et al (2) , is likely to be a secondary factor in disease causation. Cells contain many copies of the mitochondrial genome, and as such may contain a ratio of mutant or damaged mtDNA to wildtype or undamaged mtDNA (termed 'heteroplasmy'). The threshold of tolerable accumulated damage can be breached over time, ultimately leading to the disease state manifestation (reviewed in (4)). Feichtinger et al (2) present several skin diseases involving mtDNA mutations; however discussion regarding the important effects of heteroplasmy with regard to disease development is missing possibly due to space constraints. Heteroplasmic effects are of critical importance, as mtDNA mutations may not be significant to cause a disease when present at only low levels within a cell (4)). The occurrence of heteroplasmy within the mitochondria allows damage to accumulate to a point without affecting mitochondrial function. This, along with limited repair mechanisms and lack of histone body association, permits the use of mtDNA as a reliable
This article is protected by copyright. All rights reserved. Constant exposure to solar radiation, chemical and mechanical stresses places unique repair and protection pressures upon the skin compared to other organs. The damaging effects of UV irradiation upon mitochondrial damage and function in skin have been the subject of intensive recent investigation (S1, 4, S4). From our pioneering observation reported at the ESDR in 1996, the importance of using mtDNA as a reliable and sensitive biomarker of sun-exposure has been successfully exploited by our group and many others within dermatological areas including aging and cancer (reviewed in (S5, 6) ). In addition, oxidative stress-induced mtDNA damage in skin cells has recently been used as a tool for assessing the potency of cell and mitochondria-targeted antioxidants (7) and has potential for screening therapeutic compounds including anti-oxidants used in cosmetics and the diet. This is alluded to by Feichtinger et al (2) who highlight nicotinamide (vitamin B3) a compound which, as a precursor of nicotinamide adenine dinucleotide within mitochondrial energy metabolism, has provided benefit by reducing actinic keratosis (S6) and mitochondrial myopathy (S7). Feichtinger et al (2) also briefly mention the therapeutic targeting of mitochondria in skin disease using the drug dithranol as a treatment for psoriasis. The mechanism of action was described as 'damaging' to mitochondria via the uncoupling of ATP production (2,S8).
More recently, dithranol's mechanism of action has been elucidated (S9). The drug interacts specifically with the mitochondrial ubiquinone pool in keratinocyte cells subsequently inducing apoptosis by mitochondrial membrane potential disruption, causing a release in cytochrome c. This action is dependent upon the presence of a functional mETC (S9).
In the respect of a functional mETC, Feichtinger et al (2) have highlighted the important potential roles of individual mETC complexes in various skin diseases however Complex II was not explored.
This often over-looked complex was recently implicated in the ageing process of both human (S10) and mouse skin (S11). It was also reported to produce reactive oxygen species (ROS) to a similar
This article is protected by copyright. All rights reserved. 
